VOYA Investment Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13.7M | Buy |
286,279
+52,261
| +22% | +$2.29M | 0.01% | 541 |
|
|
2025
Q4 | $9.04M | Buy |
234,018
+40,918
| +21% | +$1.56M | 0.01% | 677 |
|
|
2025
Q3 | $6.81M | Buy |
193,100
+32,245
| +20% | +$1.17M | 0.01% | 766 |
|
|
2025
Q2 | $5.8M | Buy |
160,855
+105,114
| +189% | +$3.48M | 0.01% | 900 |
|
|
2025
Q1 | $1.74M | Sell |
55,741
-2,214
| -4% | -$70.2K | ﹤0.01% | 1361 |
|
|
2024
Q4 | $1.48M | Buy |
57,955
+7,076
| +14% | +$188K | ﹤0.01% | 1417 |
|
|
2024
Q3 | $1.44M | Sell |
50,879
-4,293
| -8% | -$119K | ﹤0.01% | 1463 |
|
|
2024
Q2 | $1.45M | Buy |
55,172
+10,573
| +24% | +$293K | ﹤0.01% | 1431 |
|
|
2024
Q1 | $1.35M | Sell |
44,599
-1,918
| -4% | -$56.5K | ﹤0.01% | 1502 |
|
|
2023
Q4 | $1.31M | Sell |
46,517
-563
| -1% | -$15.5K | ﹤0.01% | 1537 |
|
|
2023
Q3 | $1.28M | Sell |
47,080
-245
| -0.5% | -$7.28K | ﹤0.01% | 1514 |
|
|
2023
Q2 | $1.45M | Sell |
47,325
-4,773
| -9% | -$162K | ﹤0.01% | 1481 |
|
|
2023
Q1 | $1.88M | Sell |
52,098
-77
| -0.1% | -$2.85K | ﹤0.01% | 1379 |
|
|
2022
Q4 | $2.06M | Buy |
52,175
+4,099
| +9% | +$171K | ﹤0.01% | 1312 |
|
|
2022
Q3 | $1.93M | Sell |
48,076
-1,171
| -2% | -$50K | ﹤0.01% | 1336 |
|
|
2022
Q2 | $2.07M | Sell |
49,247
-62,853
| -56% | -$2.58M | 0.01% | 1098 |
|
|
2022
Q1 | $4.37M | Sell |
112,100
-1,852
| -2% | -$72.7K | 0.01% | 873 |
|
|
2021
Q4 | $4.54M | Buy |
113,952
+32,043
| +39% | +$1.24M | 0.01% | 875 |
|
|
2021
Q3 | $2.96M | Sell |
81,909
-1,342
| -2% | -$52.2K | 0.01% | 1013 |
|
|
2021
Q2 | $3.41M | Buy |
83,251
+10,931
| +15% | +$465K | 0.01% | 992 |
|
|
2021
Q1 | $3.15M | Buy |
72,320
+45,860
| +173% | +$2.17M | 0.01% | 997 |
|
|
2020
Q4 | $1.32M | Buy |
26,460
+5,287
| +25% | +$224K | ﹤0.01% | 1346 |
|
|
2020
Q3 | $891K | Buy |
+21,173
| New | +$908K | ﹤0.01% | 1344 |
|
Other funds holding RPRX
